Symmetry Medical (SMA) Stock Price, News & Analysis

Company Overview

Symmetry Medical Inc. (Symmetry) is a medical device solutions company, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry, and other medical device markets (including but not limited to arthroscopy, dental, laparoscopy, osteobiologic, and endoscopy segments). It also manufactures specialized non-healthcare products, primarily in the aerospace industry. The Company operates in two segments: original equipment manufacturer (OEM) solutions and symmetry surgical. On August 15, 2011, the Company acquired PSC Industries, Inc's Olsen Medical division. On December 29, 2011 it acquired the surgical instruments product portfolio from Codman & Shurtleff, Inc., a Johnson & Johnson Company.

Key Stats

• Today's Range: $35.32 to $36.83
• 50-Day Range: $13,350.00 to $16,000.00
• 52-Week Range: N/A
• Volume: 396,754 shs
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $38.50
• Consensus Rating: Buy

SMA Stock Analysis - Frequently Asked Questions

How were Symmetry Medical's earnings last quarter?

Symmetry Medical Inc (NYSE:SMA) announced its quarterly earnings data on Wednesday, May, 7th. The healthcare company reported $0.41 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.41. The healthcare company had revenue of $65.45 million for the quarter, compared to analysts' expectations of $63.63 million.
Read the conference call transcript.

When did Symmetry Medical IPO?

Symmetry Medical (SMA) raised $810 million in an initial public offering on Wednesday, April 2nd 2025. The company issued 27,000,000 shares at a price of $30.00 per share.

When did Symmetry Medical's quiet period expire?

Symmetry Medical's quiet period expired on Monday, May 12th. Symmetry Medical had issued 27,000,000 shares in its public offering on April 2nd. The total size of the offering was $810,000,000 based on an initial share price of $30.00. During Symmetry Medical's quiet period, insiders and underwriters that worked on the IPO were restricted from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

What other stocks do shareholders of Symmetry Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Symmetry Medical investors own include Consort Medical plc (CSRT.L) (CSRT), Achillion Pharmaceuticals (ACHN), Boeing (BA), Cencora (COR), Alphabet (GOOG), Illumina (ILMN) and Newcrest Mining (NCM).

Company Calendar

• Last Earnings: 5/07/2025
• Today: 6/02/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: N/A
• Industry: N/A
• Sub-Industry: Health Care Equipment
• Current Symbol: NYSE:SMA
• CIK: 1292055
• Web: N/A
• Phone: +1-574-2682252
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $38.50
• High Stock Price Target: $40.00
• Low Stock Price Target: $36.00
• Potential Upside/Downside: +5.4%
• Consensus Rating: Buy
• Rating Score (0-4): 3.25
• Research Coverage: 12 Analysts

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A